Skip to main content
Clinical Trials/IRCT20210513051276N1
IRCT20210513051276N1
Recruiting
Phase 2

Clinical trial of Comparison of the efficacy and safety of finasteride and hydroxy chloroquine on frontal fibrosing severity index in patients with frontal fibrosing alopecia

Esfahan University of Medical Sciences0 sites30 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Esfahan University of Medical Sciences
Enrollment
30
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • New cases with FFA who have not yet received any medication.
  • Patients who have previously received systemic therapy and have not received systemic medication for at least the last three months and according to clinical and dermoscopic criteria, their disease is active.
  • Patients treated with topical medication and according to clinical and dermoscopic criteria, their disease is active

Exclusion Criteria

  • Pregnancy or lactation
  • History of hypersensivity due to hydroxychloroquine or finasteride
  • Patients with severe blood dyscrasia and liver dysfunction
  • Patients with retinopathy
  • Personal history or family history of breast cancer

Outcomes

Primary Outcomes

Not specified

Similar Trials